Related Experiment Video
Updated: Jul 11, 2025

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
Nonlinear control designs and their application to cancer differentiation therapy
Yen-Che Hsiao1, Abhishek Dutta1
1Department of Electrical and Computer Engineering, University of Connecticut, Storrs, 06269, CT, USA.
Three novel controllers were developed for cancer differentiation therapy, demonstrating superior performance and robustness. The proportional-integral-derivative (PID) impulsive controller shows significant potential for improved cancer treatment strategies.
Area of Science:
- Biomedical Engineering
- Control Theory
- Computational Biology
Background:
- Cancer differentiation therapy aims to control cancer cell states.
- Existing control strategies have limitations in performance and robustness.
Purpose of the Study:
- To design and evaluate three novel controllers for cancer differentiation therapy.
- To compare the performance and robustness of new controllers against existing methods.
Main Methods:
- Development of a sigmoid-based controller incorporating an error-associated sigmoid term.
- Implementation of a polynomial dynamic inversion-based controller with a cubic error term for faster convergence.
- Design of a proportional-integral-derivative (PID) impulsive controller to enhance state convergence and reduce steady-state damping.
Main Results:
- All three designed controllers demonstrated superior performance in the considered cancer network model.
- The sigmoid-based controller reduced control effort during state transitions.
- The polynomial dynamic inversion-based controller achieved shorter convergence times.
- The PID impulsive controller exhibited significantly improved robustness compared to existing impulsive controllers, showing great potential for cancer differentiation therapy.
Conclusions:
- The novel sigmoid-based, polynomial dynamic inversion-based, and PID impulsive controllers offer enhanced performance for cancer differentiation therapy.
- The PID impulsive controller presents a promising advancement in robustness and efficacy for cancer treatment.
- These advanced control strategies hold significant potential for improving cancer differentiation therapy outcomes.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
12:41Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
Published on: December 23, 2022
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...